COMMUNIQUÉS West-GlobeNewswire

BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024
25/07/2024
Los Angeles, CA 90025, July 25, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) or (“BioSig” or "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac [...]
Full-Body MRI Innovator Ezra and Longhorn Imaging Partner to Bring Full-Body MRI to Central Texas
25/07/2024
Early cancer detection technology now available for the first time for all Central Texas area residents NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Ezra , a healthcare AI startup revolutionizing early cancer detection [...]
Oxurion Share Consolidation
25/07/2024
Oxurion Share Consolidation Leuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV (Euronext Brussels: OXUR) (the Company ), a biopharmaceutical company based in Leuven, announced today that its Board of Directors, [...]
EssilorLuxottica: Q2/H1 2024 Results - Sound revenue growth, margins expanding, two acquisitions in line with strategy
25/07/2024
Q2/H1 2024 Results Sound revenue growth, margins expanding, two acquisitions in line with strategy Revenue growing by 5.2% in Q2 at constant exchange rates 1 , +5.3% in H1 EMEA as the driving region, North America [...]
EssilorLuxottica: Résultats T2/S1 2024 - Solide croissance du chiffre d'affaires, amélioration de la marge, deux acquisitions alignées avec la stratégie du Groupe
25/07/2024
Résultats T2/S1 2024 Solide croissance du chiffre d'affaires, amélioration de la marge, deux acquisitions alignées avec la stratégie du Groupe Hausse du chiffre d’affaires du Groupe de 5,2 % au T2 à taux de change [...]
GUERBET : Chiffre d’affaires du 1er semestre 2024.
25/07/2024
Chiffre d’affaires du 1 er semestre 2024 Activité semestrielle Chiffre d’affaires du 1 er semestre : 419,2 M€, en hausse de 11,8% à TCC 1 , intégrant une accélération au 2 ème trimestre (+14,5%) Cette accélération a été [...]
GUERBET : H1 2024 revenue.
25/07/2024
H1 2024 revenue Half-yearly activity H1 revenue: €419.2m, up 11.8% at CER 1 , including an acceleration in Q2 (+14.5%) This acceleration was driven by continued catch-up in the Americas, the normalisation of orders in [...]
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
25/07/2024
RESEARCH TRIANGLE PARK, N.C., July 25, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate [...]
European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events
25/07/2024
Bagsværd, Denmark, 25 July 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy [...]
Press Release: Online availability of Sanofi’s half-year financial report for 2024
25/07/2024
Online availability of Sanofi’s half-year financial report for 2024 Paris, July 25, 2024 . Sanofi announces that its half-year financial report for the period ending June 30, 2024 is now available and has been filed [...]
Communiqué de presse : Mise en ligne du rapport financier semestriel 2024 de Sanofi
25/07/2024
Mise en ligne du rapport financier semestriel 2024 de Sanofi Paris, le 25 juillet 2024 . Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son [...]
Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT
25/07/2024
Niagara Falls, NY, July 25, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET & PET-CT imaging systems, is [...]
60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
25/07/2024
60 Degrees Pharmaceuticals has been awarded a contract with the United States Army Medical Materiel Development Activity to facilitate commercial validation of new bottle and replacement blister packaging of ARAKODA [...]
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
25/07/2024
BEDFORD, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its [...]
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven
25/07/2024
Company’s continued growth and improved cash position alleviates the need for capital raise in the foreseeable future NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, [...]
Intuitive President David J. Rosa Appointed to Intuitive Board of Directors
25/07/2024
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Intuitive President [...]
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
25/07/2024
Extends maturity of long-term debt as Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as [...]
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
25/07/2024
Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, [...]
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function
25/07/2024
- Treatment with INZ-701 shown to prevent intimal proliferation in both ENPP1-deficient and wild-type mice, supporting its potential therapeutic application beyond traditional ERT - BOSTON, July 25, 2024 (GLOBE NEWSWIRE [...]

Pages